Addus HomeCare (ADUS)
(Real Time Quote from BATS)
$119.87 USD
+1.05 (0.88%)
Updated Jul 22, 2024 11:12 AM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Price, Consensus and EPS Surprise
ADUS 119.87 +1.05(0.88%)
Will ADUS be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for ADUS based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ADUS
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?
The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant
ADUS: What are Zacks experts saying now?
Zacks Private Portfolio Services
Top 5 Outpatient and Home Healthcare Stocks for Solid Returns
Compared to Estimates, Addus HomeCare (ADUS) Q1 Earnings: A Look at Key Metrics
Addus HomeCare (ADUS) Q1 Earnings and Revenues Beat Estimates
Other News for ADUS
Addus HomeCare Announces Second Quarter 2024 Earnings Release and Conference Call
Addus HomeCare Announces Closing of Public Offering
RBC says presidential debate bodes well for managed care stocks
Addus Homecare (ADUS) Receives a Buy from Bank of America Securities
Addus HomeCare initiated with bullish view at Macquarie, here's why